Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)
| 9.51 Delayed Data As of Nov 23 |  -0.49 / -4.89%Today’s Change | 4.55 Today|||52-Week Range 15.82 | -36.17% Year-to-Date |
Latest EIGR News | Press Releases
No recent news for Eiger BioPharmaceuticals Inc.
Today’s Trading
| Previous close | 10.03 |
| Today’s open | 10.50 |
| Day’s range | 9.16 - 10.55 |
| Volume | 2,243,001 |
| Average volume (3 months) | 533,137 |
| Market cap | $326.6M |
Data as of 3:59pm ET, 11/23/2020
Growth & Valuation
| Earnings growth (last year) | +19.31% |
| Earnings growth (this year) | +77.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CNCEConcert Pharmaceutic... | +0.14 | +1.30% |
| MEIPMEI Pharma Inc | -0.01 | -0.35% |
| BYSIBeyondspring Inc | -0.18 | -1.73% |
| RDHLRedhill Biopharma Lt... | -0.21 | -2.33% |
Data as of 3:59pm ET, 11/23/2020
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$70.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
